Literature DB >> 5473601

Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality.

L W Powell, C B Campbell, E Wilson.   

Abstract

The process of iron absorption has been studied in 23 patients with idiopathic haemochromatosis, in eight with iron-deficiency anaemia, and in 20 control subjects. The initial uptake of iron by the intestinal mucosa was estimated by administering (59)Fe-ferric citrate during a standard meal together with a non-absorbable marker, (51)Cr-chromic chloride. Body iron absorption (iron retained at 14 days) was measured by whole body counting with discriminant analysis to separate the two isotopes. Thus, the fraction of the initial mucosal uptake finally retained in the body was calculated (the mucosal transport index of iron). In control subjects the mean values for mucosal uptake of iron and body iron absorption were 12.0 - SD 4.9% and 3.6 - SD 2.4%, with a mean mucosal transport index of 0.31 - SD 0.21. Mucosal iron uptake and body absorption were both considerably increased in the patients with iron-deficiency anaemia (33.5 - 15.6 and 29.8 - 17.0% respectively) and in the eight patients with idiopathic haemochromatosis treated by venesection therapy until the excess iron stores were removed (27.2 - 12.0 and 26.6 - 14.6% respectively). The mucosal transport index in all these subjects approached 1.0. Eight patients with haemochromatosis were studied before venesection therapy. The mucosal uptake of iron was within the normal range in all (mean 14.0 - 2.8%) but body iron absorption was increased in five (mean 9.1 - 4.8%). The mean mucosal transport index of iron was significantly increased in this group (0.62 - 0.28; p < 0.01). The findings suggest that the increased iron absorption in subjects with idiopathic haemochromatosis results from an abnormality of the intestinal mucosa and not from altered intraluminal factors. However, whether the aberrant mucosal cell function is a primary defect in the cell or an acquired change, dependent on humoral or corporeal factors, is unknown.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5473601      PMCID: PMC1553114          DOI: 10.1136/gut.11.9.727

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Reduction of gastric iron-binding protein in haemochromatosis. A previously unrecognised metabolic defect.

Authors:  P S Davis; C G Luke; D J Deller
Journal:  Lancet       Date:  1966-12-31       Impact factor: 79.321

2.  Use of barium sulfate as an unabsorbable fecal marker.

Authors:  W G Figueroa; T Jordan; S H Bassett
Journal:  Am J Clin Nutr       Date:  1968-11       Impact factor: 7.045

3.  [The determination of iron absorption and iron retention with a total body counter especially, in patient with idiopathic hemochromatosis].

Authors:  J A Flendrig; J H van Tongeren; B Hogeweg; C W Verhoef
Journal:  Ned Tijdschr Geneeskd       Date:  1968-05-11

Review 4.  Hemochromatosis: dietary and genetic aspects.

Authors:  R W Charlton; T H Bothwell
Journal:  Prog Hematol       Date:  1966

5.  The estimation of fat absorption in man with the use of double isotopes 131BaSO4 and 131-iodine triolein.

Authors:  B Seife; M E Shils; G Amster
Journal:  J Lab Clin Med       Date:  1969-07

6.  The iron content of jejunal mucosa obtained by Crosby's biopsy in hemochromatosis and hemosiderosis.

Authors:  G Astaldi; G Meardi; T Lisino
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

7.  Effect of the exocrine pancreatic secretions on iron absorption.

Authors:  H Kavin; R W Charlton; P Jacobs; R Green; J D Torrance; T H Bothwell
Journal:  Gut       Date:  1967-12       Impact factor: 23.059

8.  Absorption of hemoglobin iron: the role of a heme-splitting substance in the intestinal mucosa.

Authors:  L R Weintraub; M B Weinstein; H J Huser; S Rafal
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores.

Authors:  L W Powell; M J Thomas
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

10.  [The iron content of the duodeno-jejunal villi. Iron absorption viewed histologically].

Authors:  D Cattan; C Marche; G P Jori; C Debray
Journal:  Nouv Rev Fr Hematol       Date:  1967 Mar-Apr
View more
  18 in total

1.  Fetal liver iron overload: the role of MR imaging.

Authors:  Marie Cassart; Freddy Efraim Avni; Laurent Guibaud; Marc Molho; Nicky D'Haene; Alain Paupe
Journal:  Eur Radiol       Date:  2010-09-04       Impact factor: 5.315

2.  Absence of macrophage and presence of plasmacellular iron storage in the terminal duodenum of patients with hereditary haemochromatosis.

Authors:  J Düllmann; U Wulfhekel; A Mohr; K Riecken; K Hausmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Duodenal iron proteins in idiopathic hemochromatosis.

Authors:  P Whittaker; B S Skikne; A M Covell; C Flowers; A Cooke; S R Lynch; J D Cook
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 4.  Iron and the liver.

Authors:  M Barry
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

Review 5.  Hereditary hemochromatosis and transferrin receptor 2.

Authors:  Juxing Chen; Caroline A Enns
Journal:  Biochim Biophys Acta       Date:  2011-08-16

6.  Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ.

Authors:  P L Dabkowski; P W Angus; R A Smallwood; J Ireton; R M Jones
Journal:  BMJ       Date:  1993-06-26

7.  Relationship between serum ferritin and total body iron stores in idiopathic haemochromatosis.

Authors:  L W Powell; J W Halliday; J L Cowlishaw
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

8.  Genes that modify the hemochromatosis phenotype in mice.

Authors:  J E Levy; L K Montross; N C Andrews
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 9.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

10.  Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.

Authors:  T Kelleher; E Ryan; S Barrett; M Sweeney; V Byrnes; C O'Keane; J Crowe
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.